The Pharma Data

MAY 27, 2022

Janssen) entered into an exclusive worldwide license and collaboration agreement with Legend Biotech USA, Inc. We are deeply thankful to the patients, their families, the nurses, and the teams of researchers and study centres who have participated in the clinical study of cilta-cel and made today’s approval possible.”.

Therapies 52

Therapies Treatment Pharmaceutical Companies Nurses 52

The Pharma Data

JANUARY 24, 2021

Gritstone Oncology , based in Emeryville, California, announced that it is advancing development of its own second-generation vaccine against COVID-19. It is a virus-based therapeutic vaccine that encodes neoantigens picked by NEC’s Neoantigen Prediction System. The drug was licensed from Immutep Limited. Read on to see.

Long-Term Care Facilities 52

Long-Term Care Facilities Trials Virus Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

We are also very encouraged by recently announced promising vaccine results; however, there remains a need to treat patients who develop COVID-19, especially as some may not have had access to or were not protected by vaccination. About Regeneron.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

MAY 14, 2021

If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using our products. Statements on this website have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure or prevent any disease.

Production 52

Production Nurses Doctors Licensing 52

The Pharma Data

NOVEMBER 21, 2020

We are also very encouraged by recently announced promising vaccine results; however, there remains a need to treat patients who develop COVID-19, especially as some may not have had access to or were not protected by vaccination.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

JANUARY 26, 2021

Lilly has received feedback from front-line nurses and doctors administering these infusions regarding the complexity and time requirements for preparation and administration. It remains under review by the FDA. It was identified from a blood sample taken from one of the first U.S. patients who recovered from COVID-19. .

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52

The Pharma Data

MAY 13, 2021

I could hear doctors and nurses speaking in hushed tones…. And Mary-Anne, a nurse from Arkansas, who says…. And I was rushed to hospital in the back of an ambulance… As paramedics desperately tried to keep me alive. There were countless sensors and monitors hissing and beeping around me. But I was paying attention to any of that.

Production 52

Production Packaging Doctors Research 52

Drug & Device Law

DECEMBER 29, 2023

Equally bad, Hrymoc effectively read a New Jersey statute, §2A:58C-5(c), which precludes punitive damages where a “device” was “licensed” by the FDA, out of existence. These vaccines are the epitome, indeed the apotheosis, of a “covered countermeasure” against the COVID-19 pandemic. The plaintiff in M.T. must be a piece of work.

Testimonials 105

Testimonials FDA Drugs Vaccine 105

Drug & Device Law

MAY 15, 2023

Suffice it to say that it covers the administration of COVID vaccines – the heart of this nation’s response to the COVID-19 pandemic. The relevant facts were quite concisely stated: In the fall of 2021, [plaintiff’s] 15-year-old [daughter] visited [defendant’s] pharmacy seeking to be vaccinated for COVID-19 without parental consent.

Vaccine 59

Vaccine Pharmacy Hospitals Licensing 59